Log in to MyKarger to check if you already have access to this content.
Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price. Rent/Cloud Rent for 48h to view Buy Cloud Access for unlimited viewing via different devices Synchronizing in the ReadCube Cloud Printing and saving restrictions apply Rental: USD 8.50* The final prices may differ from the prices shown due to specifics of VAT rules.
Article / Publication Details AbstractBackground: The potential signaling pathway of TSA suppressing TF expression induced by thrombin was unknown. Thus, the transcription of TF in HUVECs, and the expressions of DCF, phospho-p38 MAPK, NADPH oxidase 4, PAR-1 and NF-B were detected in our study. Methods: HUVECs were randomly divided into control group, thrombin treated group (with 5 U/ml of thrombin) and 4 TSA treated groups (with 5 U/ml of thrombin plus TSA with 4 different concentrations of 1 μg/ml, 10 μg/ml, 100 μg/ml and 1 mg/ml respectively). Results: After incubation with thrombin for 6 hrs at 37℃, the results showed increased TF mRNA, TF procoagulant activity and antigen of TF in HUVECs of thrombin treated group (P
S. Karger AG, Basel
Article / Publication Details Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
留言 (0)